Forum Financial Management LP bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 995 shares of the company’s stock, valued at approximately $239,000.
A number of other institutional investors and hedge funds have also made changes to their positions in HCA. RFP Financial Group LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $28,000. Covestor Ltd grew its holdings in shares of HCA Healthcare by 122.7% during the first quarter. Covestor Ltd now owns 167 shares of the company’s stock valued at $42,000 after buying an additional 92 shares during the last quarter. Private Trust Co. NA purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $33,000. Eagle Bay Advisors LLC grew its holdings in shares of HCA Healthcare by 56.7% during the third quarter. Eagle Bay Advisors LLC now owns 210 shares of the company’s stock valued at $39,000 after buying an additional 76 shares during the last quarter. Finally, Old North State Trust LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $40,000. Institutional investors own 64.60% of the company’s stock.
Insiders Place Their Bets
In other HCA Healthcare news, CFO Bill B. Rutherford sold 30,000 shares of HCA Healthcare stock in a transaction on Friday, February 3rd. The shares were sold at an average price of $258.19, for a total value of $7,745,700.00. Following the completion of the transaction, the chief financial officer now directly owns 81,632 shares of the company’s stock, valued at approximately $21,076,566.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other HCA Healthcare news, CFO Bill B. Rutherford sold 30,000 shares of HCA Healthcare stock in a transaction on Friday, February 3rd. The shares were sold at an average price of $258.19, for a total value of $7,745,700.00. Following the completion of the transaction, the chief financial officer now directly owns 81,632 shares of the company’s stock, valued at approximately $21,076,566.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Kathleen M. Whalen sold 1,734 shares of HCA Healthcare stock in a transaction on Friday, February 17th. The stock was sold at an average price of $263.61, for a total transaction of $457,099.74. Following the completion of the transaction, the senior vice president now directly owns 9,962 shares of the company’s stock, valued at $2,626,082.82. The disclosure for this sale can be found here. Insiders sold 79,899 shares of company stock valued at $20,460,494 in the last three months. Corporate insiders own 1.60% of the company’s stock.
HCA Healthcare Price Performance
HCA Healthcare (NYSE:HCA – Get Rating) last announced its quarterly earnings results on Friday, January 27th. The company reported $4.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.79 by ($0.15). The company had revenue of $15.50 billion during the quarter, compared to the consensus estimate of $15.51 billion. HCA Healthcare had a net margin of 9.37% and a negative return on equity of 1,260.96%. Equities research analysts expect that HCA Healthcare, Inc. will post 17.16 earnings per share for the current fiscal year.
HCA Healthcare declared that its board has approved a share repurchase program on Friday, January 27th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the company to purchase up to 4.2% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.
HCA Healthcare Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, March 31st. Shareholders of record on Friday, March 17th were issued a $0.60 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.56. This represents a $2.40 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date was Thursday, March 16th. HCA Healthcare’s payout ratio is currently 12.48%.
Wall Street Analysts Forecast Growth
HCA has been the topic of several research reports. Oppenheimer raised their target price on shares of HCA Healthcare from $235.00 to $270.00 and gave the stock an “outperform” rating in a report on Thursday, January 19th. Cowen raised their target price on shares of HCA Healthcare from $238.00 to $292.00 and gave the stock an “outperform” rating in a report on Monday, January 30th. SVB Leerink raised their target price on shares of HCA Healthcare from $238.00 to $286.00 and gave the stock an “outperform” rating in a report on Friday, December 16th. Citigroup raised their target price on shares of HCA Healthcare from $280.00 to $293.00 and gave the stock a “buy” rating in a report on Monday, January 30th. Finally, Loop Capital lifted their price target on shares of HCA Healthcare from $240.00 to $285.00 in a research note on Monday, January 30th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $269.41.
About HCA Healthcare
HCA Healthcare, Inc is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.
Recommended Stories
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- MarketBeat Week in Review – 3/27 – 3/31
- What is a Gold IRA, and is it a Viable Investment?
- Is Braze Inc Ready To Rocket Higher?
- Mullen Automotive Makes Deliveries; Short-Squeeze Possible
- Can Frontline Maintain This Momentum?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Get Rating).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.